Our aim was to determine the impact of targeted blood pressure modifications on cerebral blood flow in ischemic moyamoya disease patients assessed by single-photon emission computed tomography (SPECT). From March to September 2018, we prospectively collected data of 154 moyamoya disease patients and selected 40 patients with ischemic moyamoya disease. All patients underwent in-hospital blood pressure monitoring to determine the mean arterial pressure baseline values. The study cohort was subdivided into two subgroups: (1) Group A or relative high blood pressure (RHBP) with an induced mean arterial pressure 10–20% higher than baseline and (2) Group B or relative low blood pressure (RLBP) including patients with mean arterial pressure 10–20% lower than baseline. All patients underwent initial SPECT study on admission-day, and on the following day, every subgroup underwent a second SPECT study under their respective targeted blood pressure values. In general, RHBP patients showed an increment in perfusion of 10.13% (SD 2.94%), whereas RLBP patients showed a reduction of perfusion of 12.19% (SD 2.68%). Cerebral blood flow of moyamoya disease patients is susceptible to small blood pressure changes, and cerebral autoregulation might be affected due to short dynamic blood pressure modifications.
Objective: To elucidate the neuroradiological characteristics, clinical manifestations, and surgical outcomes of intracranial cerebellar solitary fibrous tumors (SFTs) to improve diagnostic accuracy and therapeutic strategies. Method: A retrospective analysis was conducted on the clinical data of two histopathologically confirmed cases of cerebellar SFT, supplemented by a review of the relevant literature. Results: Both patients underwent total surgical excision followed by postoperative radiotherapy. At the latest follow-up, neither patient showed radiological evidence of tumor recurrence (Case 1: 18 months; Case 2: 12 months]). Given the potential for late recurrence in SFTs, long-term surveillance is mandatory. Conclusion: Intracranial cerebellar SFTs are rare neoplasms that are frequently misdiagnosed despite exhibiting distinctive magnetic resonance imaging (MRI) features. Definitive diagnosis relies on histopathological and immunohistochemical analyses. In this study, MRI demonstrated T1-weighted imaging (T1WI) hypointensity or isointensity, T2-weighted imaging (T2WI) heterogeneity, and inconsistent post-contrast enhancement. Immunohistochemical evaluation revealed positivity for CD34, CD99, and STAT6. Prompt surgical intervention accompanied by adjuvant therapy was associated with a favorable prognosis.